Note 20.  Reportable Segments

 

The Company has two reportable segments: (i) e-Commerce Operations, which involves acquiring and leasing, primarily an e-commerce platform to collaborate with businesses to optimize their ability to sell their goods online, domestically, and internationally, and enabling customers and partners to optimize their e-commerce presence and revenue, and other related businesses and (ii) Healthcare Operations, which provides TPA, data management, COVID-19 related diagnostics and vaccinations, prescription pharmaceuticals, compounded medications, telepharmacy services, anti-retroviral medications, medication therapy management, the supply of prescription medications to long-term care facilities, medication adherence packaging, contracted pharmacy services for 340B covered entities under the 340B Drug Discount Pricing Program, and health practice risk management. This organizational structure aligns with how the Company’s CODMs manage the business, including resource allocation and performance assessment, and further aligns with the Company’s product categories and the key markets the Company serves.

 

The CODMs include the Company’s Chief Executive Officer and Chief Financial Officer.

 

The CODMs do not review segment assets and segment expenses at a level different than what is reported in the Company’s Consolidated Balance Sheets and Consolidated Statements of Operations and Comprehensive Loss. While the Company believes there are synergies between the two reportable segments, the segments are managed separately because each requires different business strategies. Accounting policies associated with our operating segments are generally the same as those described in Note 1.

 

The following tables provide information about the Company’s reportable segments (in thousands):

 

Year Ended December 31, 2025

 

e-Commerce Operations

  

Healthcare Operations

  

Eliminations

  

Total

 

e-Commerce revenue

 $14,608  $  $  $14,608 

Pharmacy prescription and other revenue, net of PBM fees

     35,704      35,704 

Pharmacy 340B contract revenue

     4,010      4,010 

Revenues, net

  14,608   39,714      54,322 
                 

Expenses:

                

Cost of revenue

  11,251   32,165      43,416 

Selling, general and administrative

  2,958   3,085      6,043 

Salaries, wages and payroll taxes

  2,905   7,802      10,707 

Professional fees

  1,510   754      2,264 

Depreciation and amortization

  278   262      540 

Intangible asset amortization

  102         102 

Loss on settlement of litigation

     250      250 

Total expenses

  19,004   44,318      63,322 

Operating loss

  (4,396)  (4,604)     (9,000)

Interest expense

  7   57      64 

Other expense

  434   965      1,399 

Loss before income taxes

  (4,837)  (5,626)     (10,463)

Income taxes

           - 

Net loss

 $(4,837) $(5,626) $  $(10,463)
                 

Year Ended December 31, 2024

 

e-Commerce Operations

  

Healthcare Operations

  

Eliminations

  

Total

 

e-Commerce revenue

 $13,791  $  $  $13,791 

Pharmacy prescription and other revenue, net of PBM fees

     41,907      41,907 

Pharmacy 340B contract revenue

     10,384      10,384 

Revenues, net

  13,791   52,291      66,082 
                 

Expenses:

                

Cost of revenue

  10,356   38,718      49,074 

Selling, general and administrative

  2,907   3,272      6,179 

Salaries, wages and payroll taxes

  3,599   9,704      13,303 

Impairment loss

     13,653      13,653 

Professional fees

  2,900   1,741   (240)  4,401 

Depreciation and amortization

  438   350      788 

Intangible asset amortization

  101   1,608      1,709 

Total expenses

  20,301   69,046   (240)  89,107 

Operating loss

  (6,510)  (16,755)  240   (23,025)

Interest expense

  13   68      81 

Other (income) expense

  (647)  (244)  240   (651)

Loss before income taxes

  (5,876)  (16,579)     (22,455)

Income taxes

  (71)        (71)

Net loss

 $(5,947) $(16,579) $  $(22,526)

 

  

e-Commerce Operations

  

Healthcare Operations

  

Eliminations

  

Total

 

Total assets as of December 31, 2025

 $12,748  $14,717  $  $27,465 
                 

Total assets as of December 31, 2024

 $19,044  $18,033  $  $37,077 

 

Historical Timeline

Fiscal YearFiled
2025Mar 31, 2026Showing above
2024Mar 24, 2025
2023Apr 11, 2024

About Segments Disclosures

Segment disclosures break a company into its reportable operating units, revealing revenue, profit, and asset allocation that consolidated financial statements obscure. Under ASC 280, segments must match how the chief operating decision maker views the business, providing a window into internal management structure and resource allocation priorities.

Key signals: compare segment margins to identify which units drive profitability and which destroy value. Watch for changes in the number of reportable segments — segment aggregation or disaggregation often coincides with strategic shifts or attempts to obscure declining performance. Intersegment elimination patterns reveal internal pricing practices. The reconciliation between segment totals and consolidated figures exposes corporate overhead allocation and unallocated items. Geographic revenue concentration highlights regulatory and currency exposure. Compare segment-level capital expenditure against segment revenue to assess where management is investing for future growth versus harvesting existing assets.